T

The Movement Disorder Clinic of Oklahoma | Tulsa, OK

Research site

(Unclaimed)

Location

7134 S Yale Avenue, Suite 205, Tulsa, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

Carbidopa

ABBV-951

Levodopa

PF-06649751

APL-130277

Prasinezumab

Apokyn

SEP-363856

IPX203

IPX066

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 24 total trials

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease (BeyoND)

This is a multi-center, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa (LD/CD) delivered via a pump system as a...

Active, not recruiting

Parkinson's Disease

Drug: ND0612

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab...

Active, not recruiting

Parkinsons Disease

Drug: Placebo

Drug: Prasinezumab

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease (PASADENA)

This multicenter, randomized, double-blind, placebo-controlled, Phase 2 study will evaluate the efficacy of intravenous prasinezumab (RO7046015/PRX00...

Active, not recruiting

Parkinson's Disease

Drug: RO7046015

Drug: Placebo

Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot fr...

Active, not recruiting

Parkinson's Disease (PD)

Drug: ABBV-951

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Part...

Enrolling

Parkinson Disease

Drug: Placebo

Drug: CVN424 75 mg